Evasion of neutralizing antibodies and enhanced anti-tumor effects of hexon-modified Delta-24-RGD oncolytic adenovirus.

被引：0
|
作者：
Shin, Dong Ho [1 ]
Nguyen, Teresa T. [1 ]
Jiang, Hong [2 ]
Fan, Xuejun [2 ]
Yi, Yanhua [2 ]
Sohoni, Sagar S. [2 ]
Gupta, Sumit [2 ]
Ossimetha, Ashley [2 ]
Gomez-Manzano, Candelaria [2 ]
Fueyo, Juan [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1912
引用
收藏
页数：2
相关论文
共 15 条
  • [1] DELTA-24-RGD ONCOLYTIC ADENOVIRUS MEDIATES ANTI-TUMOR EFFECT IN LOCALIZED AND DISSEMINATED AT/RT MURINE MODELS
    Garcia-Moure, Marc
    Gonzalez Huarriz, Marisol
    Laspidea, Virginia
    Marrodan, Lucia
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    Patino-Garcia, Ana
    Alonso, Marta M.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 192 - 192
  • [2] A CHIMERIC ONCOLYTIC ADENOVIRUS CIRCUMVENTS NEUTRALIZING ANTIBODIES DEVELOPED BY PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH DELTA-24-RGD
    Shin, Dong Ho
    Jiang, Hong
    Gillard, Andrew
    Fan, Xuejun
    Singh, Sanjay
    Lopez-Rivas, Andres
    He, Jiasen
    Gumin, Joy
    Lang, Frederick
    Gomez-Manzano, Candelaria
    Fueyo-Margareto, Juan
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [3] ONCOLYTIC ADENOVIRUS DELTA-24-RGD EXERTS A POTENT ANTI-TUMOR EFFECT IN PRECLINICAL MODELS OF ATYPICAL TERATOID/RHABDOID TUMORS
    Garcia Moure, M.
    Gonzalez Huarriz, M.
    Marrodan, L.
    Patino-Garcia, A.
    Alonso, M. M.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 47 - 47
  • [4] Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
    Jiang, Hong
    Clise-Dwyer, Karen
    Ruisaard, Kathryn E.
    Fan, Xuejun
    Tian, Weihua
    Gumin, Joy
    Lamfers, Martine L.
    Kleijn, Anne
    Lang, Frederick F.
    Yung, Wai-Kwan Alfred
    Vence, Luis M.
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    [J]. PLOS ONE, 2014, 9 (05):
  • [5] Delta-24-RGD Adenoviral Therapy Directs Oncolytic and Immune-Mediated Anti-Tumor Effects in Recurrent Malignant Glioma Patients
    Traylor, Jeffrey I.
    Kuo, John S.
    [J]. NEUROSURGERY, 2019, 84 (01) : E11 - E12
  • [6] Oncolytic adenovirus delta-24-RGD induces efficacious antiglioma activity in brain tumor stem cell models
    Jiang, Hong
    Gomez-Manzano, Candelaria
    Yokoyama, Tomohisa
    Alonso, Marta
    Kondo, Seiji
    Xu, Jing
    Bekele, B. Nebiyou
    Colman, Howard
    Lang, Frederick
    Fueyo, Juan
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 496 - 496
  • [7] ACTIVATING THE IMMUNITY WITHIN THE TUMOR USING VIROIMMUNOTHERAPY: DELTA-24-RGD ONCOLYTIC ADENOVIRUS ARMED WITH THE IMMUNOPOSITIVE REGULATOR GITRL
    Rivera-Molina, Yisel
    Fueyo, Juan
    Jiang, Hong
    Nguyen, Teresa
    Shin, Dong Ho
    Youssef, Gilbert
    Fan, Xuejun
    Gumin, Joy
    Alonso, Marta M.
    Phadnis, Sheetal
    Lang, Frederick
    Gomez-Manzano, Candelaria
    [J]. NEURO-ONCOLOGY, 2019, 21 : 87 - 87
  • [8] GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
    Rivera-Molina, Yisel
    Jiang, Hong
    Fueyo, Juan
    Nguyen, Teresa
    Shin, Dong Ho
    Youssef, Gilbert
    Fan, Xuejun
    Gumin, Joy
    Alonso, Marta M.
    Phadnis, Sheetal
    Lang, Frederick F.
    Gomez-Manzano, Candelaria
    [J]. NEURO-ONCOLOGY ADVANCES, 2019, 1 (01)
  • [9] Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Candelaria
    Yung, W. K. Alfred
    Sawaya, Raymond
    Weinberg, Jeffrey S.
    Prabhu, Sujit S.
    Rao, Ganesh
    Fuller, Gregory N.
    Aldape, Kenneth D.
    Gumin, Joy
    Vence, Luis M.
    Wistuba, Ignacio
    Rodriguez-Canales, Jaime
    Villalobos, Pamela A.
    Dirven, Clemens M. F.
    Tejada, Sonia
    Valle, Ricardo D.
    Alonso, Marta M.
    Ewald, Brett
    Peterkin, Joanna J.
    Tufaro, Frank
    Fueyo, Juan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) : 1419 - +
  • [10] THE ONCOLYTIC VIRUS DELTA-24-RGD IN COMBINATION WITH AN AGONISTIC CD40 MAB INDUCES A DURABLE AND SYNERGISTIC ANTI-TUMOR IMMUNE EFFECT IN DIPG PRECLINICAL MODELS
    Labiano, Sara
    Laspidea, Virginia
    Garcia-Moure, Marc
    Puigdelloses, Montserrat
    Becher, Oren J.
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    Patino-Garcia, Ana
    Alonso, Marta M.
    [J]. NEURO-ONCOLOGY, 2021, 23 : 26 - 27
12